BFLY — Butterfly Network, Inc.

Butterfly Network, Inc. Q4 and FY 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Revenue: $31.5 million, a 41% increase year-over-year.
• Full Year Revenue: $97.6 million, up 19% from 2024.
• Gross Profit: $21.2 million in Q4, a 55% increase; gross margin improved to 67%.
• Adjusted EBITDA: Loss of $3.2 million in Q4, improved from a loss of $9.1 million in Q4 2024; full-year adjusted EBITDA loss of $26.5 million, down from $38.9 million in 2024.
• Cash Position: $154.5 million at year-end; positive cash flow of $6.3 million in Q4, marking the lowest annual cash use in company history at $19.4 million.

2. Strategic Updates and Business Highlights

• Core Business Growth: Revenue from the Point-of-Care Ultrasound (POCUS) segment grew 15% year-over-year, with significant enterprise deal closures and a successful launch of the Compass AI platform.
• Butterfly Embedded: The new strategic focus on semiconductor-based ultrasound technology, highlighted by a $74 million partnership with Midjourney, which contributed $6.8 million in Q4 revenue.
• Expansion Plans: Plans to enter the home care market with a potential commercial agreement expected in 2026, which could represent a $40 million–$50 million revenue opportunity if successful.
• R&D Initiatives: Development of the P5.1 chip and future Apollo chip, aimed at enhancing imaging capabilities and expanding applications in healthcare.

3. Forward Guidance and Outlook

• Q1 2026 Revenue Guidance: Expected between $24 million and $28 million, with anticipated adjusted EBITDA loss of $8 million to $10 million due to seasonal expenses.
• Full Year 2026 Revenue Guidance: Projected between $117 million and $121 million, representing a 20%-24% growth. Adjusted EBITDA loss expected to be between $21 million and $25 million.

4. Bad News, Challenges, or Points of Concern

• International Revenue Decline: International revenue decreased by 6% year-over-year in Q4, primarily due to a significant drop in iQ+ sales.
• Market Competition: The medical device market remains highly competitive, with concerns about the sustainability of growth against larger traditional ultrasound companies.
• Regulatory and Economic Headwinds: Ongoing uncertainties related to tariffs and regulatory processes, particularly concerning FDA approvals, may impact future growth.

5. Notable Q&A Insights

• Butterfly Embedded Pipeline: The company is actively engaging with multiple partners beyond Midjourney, indicating a robust pipeline for future revenue contributions.
• Home Care Market Potential: The executives expressed confidence in the home care business as a significant growth driver, emphasizing its role in reducing hospital readmissions and costs.
• AI Integration: The Compass AI platform is expected to enhance workflow efficiency for healthcare providers, making it easier to integrate ultrasound into daily practices.
• Medical School Partnerships: There is strong demand from medical schools for ultrasound training, which could lead to increased sales as new graduates enter the workforce.

Overall, Butterfly Network demonstrated strong growth in Q4 2025, with strategic initiatives positioning the company for future expansion, despite facing challenges in international markets and competitive pressures.